These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 25863962)

  • 1. Rules of providing cord blood for induced pluripotent stem cells for research.
    Nishiwaki S
    Cytotherapy; 2015 Jul; 17(7):1008. PubMed ID: 25863962
    [No Abstract]   [Full Text] [Related]  

  • 2. Will iPS cells enhance therapeutic applicability of cord blood cells and banking?
    Broxmeyer HE
    Cell Stem Cell; 2010 Jan; 6(1):21-4. PubMed ID: 20074533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can cord blood banks transform into induced pluripotent stem cell banks?
    Zhou H; Rao MS
    Cytotherapy; 2015 Jun; 17(6):756-764. PubMed ID: 25770678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of induced pluripotent stem cells from human cord blood.
    Haase A; Olmer R; Schwanke K; Wunderlich S; Merkert S; Hess C; Zweigerdt R; Gruh I; Meyer J; Wagner S; Maier LS; Han DW; Glage S; Miller K; Fischer P; Schöler HR; Martin U
    Cell Stem Cell; 2009 Oct; 5(4):434-41. PubMed ID: 19796623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Translational research of cell sheet-based myocardial regeneration therapy].
    Miyagawa S
    Nihon Yakurigaku Zasshi; 2016 May; 147(5):269-71. PubMed ID: 27181720
    [No Abstract]   [Full Text] [Related]  

  • 6. Stem cells, progenitors & regenerative medicine: A retrospection.
    Bhartiya D
    Indian J Med Res; 2015 Feb; 141(2):154-61. PubMed ID: 25900949
    [No Abstract]   [Full Text] [Related]  

  • 7. Strategies for Achieving Measurement Assurance for Cell Therapy Products.
    Simon CG; Lin-Gibson S; Elliott JT; Sarkar S; Plant AL
    Stem Cells Transl Med; 2016 Jun; 5(6):705-8. PubMed ID: 27386605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality control guidelines for clinical-grade human induced pluripotent stem cell lines.
    Sullivan S; Stacey GN; Akazawa C; Aoyama N; Baptista R; Bedford P; Bennaceur Griscelli A; Chandra A; Elwood N; Girard M; Kawamata S; Hanatani T; Latsis T; Lin S; Ludwig TE; Malygina T; Mack A; Mountford JC; Noggle S; Pereira LV; Price J; Sheldon M; Srivastava A; Stachelscheid H; Velayudhan SR; Ward NJ; Turner ML; Barry J; Song J
    Regen Med; 2018 Oct; 13(7):859-866. PubMed ID: 30205750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a Xeno-Free Feeder-Layer System from Human Umbilical Cord Mesenchymal Stem Cells for Prolonged Expansion of Human Induced Pluripotent Stem Cells in Culture.
    Zou Q; Wu M; Zhong L; Fan Z; Zhang B; Chen Q; Ma F
    PLoS One; 2016; 11(2):e0149023. PubMed ID: 26882313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Stem cell research using large animals].
    Hanazono Y
    Rinsho Ketsueki; 2013 Apr; 54(4):329-35. PubMed ID: 23666213
    [No Abstract]   [Full Text] [Related]  

  • 11. Concise review: Cord blood banking, transplantation and induced pluripotent stem cell: success and opportunities.
    Rao M; Ahrlund-Richter L; Kaufman DS
    Stem Cells; 2012 Jan; 30(1):55-60. PubMed ID: 22069231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derivation of GMP-compliant integration-free hiPSCs using modified mRNAs.
    Durruthy JD; Sebastiano V
    Methods Mol Biol; 2015; 1283():31-42. PubMed ID: 25304205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cell therapy for Parkinson's disease].
    Morizane A; Takahashi J
    Nihon Yakurigaku Zasshi; 2016 May; 147(5):264-8. PubMed ID: 27181719
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative transcriptomic analysis of endothelial progenitor cells derived from umbilical cord blood and adult peripheral blood: Implications for the generation of induced pluripotent stem cells.
    Gao X; Yourick JJ; Sprando RL
    Stem Cell Res; 2017 Dec; 25():202-212. PubMed ID: 29156376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal Transplantation of Human Dopaminergic Neurons Differentiated From Induced Pluripotent Stem Cells Derived From Umbilical Cord Blood Using Lentiviral Reprogramming.
    Effenberg A; Stanslowsky N; Klein A; Wesemann M; Haase A; Martin U; Dengler R; Grothe C; Ratzka A; Wegner F
    Cell Transplant; 2015; 24(10):2099-112. PubMed ID: 25420114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic transcriptome priming gates lineage-specific differentiation potential of human-induced pluripotent stem cell states.
    Lee JH; Lee JB; Shapovalova Z; Fiebig-Comyn A; Mitchell RR; Laronde S; Szabo E; Benoit YD; Bhatia M
    Nat Commun; 2014 Dec; 5():5605. PubMed ID: 25465724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and functional analyses of motor neurons generated from human cord-blood-derived induced pluripotent stem cells.
    Naujock M; Stanslowsky N; Reinhardt P; Sterneckert J; Haase A; Martin U; Kim KS; Dengler R; Wegner F; Petri S
    Stem Cells Dev; 2014 Dec; 23(24):3011-20. PubMed ID: 25007389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced pluripotent stem (iPS) cells: a new source for cell-based therapeutics?
    de Lázaro I; Yilmazer A; Kostarelos K
    J Control Release; 2014 Jul; 185():37-44. PubMed ID: 24746625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of adipose-derived stem cells in cord blood cultures stimulates their pluripotent differentiation.
    Tsagias N; Kouzi-Koliakos K; Koliakos I; Kostidou E; Karagiannis V; Daniilidis A; Koliakos G
    Transplant Proc; 2009 Dec; 41(10):4340-4. PubMed ID: 20005395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of non-transgenic iPS cells from human cord blood CD34
    Haase A; Göhring G; Martin U
    Stem Cell Res; 2017 May; 21():71-73. PubMed ID: 28677540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.